# SODIUM PHOSPHATE, DIBASIC, DIHYDRATE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid1074250
Categories: industrial, pharma
Identifier: DTXSID1074250

> SODIUM PHOSPHATE, DIBASIC, DIHYDRATE. EPA CPDat observed this chemical in 2 composition records across product categories including Laboratory supplies. Assessed from 21 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 2 composition records across product categories including Laboratory supplies.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 2 composition records across product categories including Laboratory supplies.
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 55 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 55 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION; Maximum daily exposure: 52 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 12 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY, METERED; Potency: 3 mg/1ml
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 1.2 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 18 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Potency: 2.5 mg/1ml
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 137 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 20 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.14 %w/v
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Potency: 0.25 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: GEL; Potency: NA
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 4 mg
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._